• Je něco špatně v tomto záznamu ?

Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study

M. Blaho, J. Macháčková, P. Dítě, P. Holéczy, P. Šedivý, R. Psár, Z. Švagera, D. Vilímek, D. Toman, O. Urban, M. Bužga

. 2022 ; 32 (11) : 3666-3674. [pub] 20220919

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032833
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Public Health Database (ProQuest) od 1997-02-01 do Před 1 rokem

Odkazy

PubMed 36121606
DOI 10.1007/s11695-022-06278-4
Knihovny.cz E-zdroje

INTRODUCTION: Pancreatic steatosis (PS) has both metabolic consequences and local effects on the pancreas itself. Magnetic resonance imaging (MRI) is the most reliable non-invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. METHODS: Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. RESULTS: We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue (VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. CONCLUSIONS: Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032833
003      
CZ-PrNML
005      
20230131151404.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11695-022-06278-4 $2 doi
035    __
$a (PubMed)36121606
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Blaho, Martin $u Department of Internal Medicine and Cardiology, Division of Gastroenterology, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Internal Medicine II - Gastroenterology and Geriatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic
245    10
$a Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study / $c M. Blaho, J. Macháčková, P. Dítě, P. Holéczy, P. Šedivý, R. Psár, Z. Švagera, D. Vilímek, D. Toman, O. Urban, M. Bužga
520    9_
$a INTRODUCTION: Pancreatic steatosis (PS) has both metabolic consequences and local effects on the pancreas itself. Magnetic resonance imaging (MRI) is the most reliable non-invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. METHODS: Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. RESULTS: We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue (VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. CONCLUSIONS: Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    12
$a morbidní obezita $x chirurgie $7 D009767
650    12
$a bariatrická chirurgie $7 D050110
650    _2
$a pankreas $x diagnostické zobrazování $x metabolismus $7 D010179
650    12
$a ztučnělá játra $x patologie $7 D005234
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a nitrobřišní tuk $x metabolismus $7 D050152
650    _2
$a obezita $x metabolismus $7 D009765
650    12
$a metabolický syndrom $x diagnostické zobrazování $x metabolismus $7 D024821
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Macháčková, Jitka $u Department of Internal Medicine and Cardiology, Division of Gastroenterology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Dítě, Petr $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Holéczy, Pavol $u Department of Surgery, Vitkovice Hospital, Ostrava, Czech Republic $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Šedivý, Petr $u MR Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Psár, Robert $u Department of Radiology, Vitkovice Hospital, Ostrava, Czech Republic $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic
700    1_
$a Švagera, Zdeněk $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Vilímek, Dominik $u Department of Cybernetics and Biomedical Engineering, VSB-Technical University of Ostrava, Ostrava, Czech Republic
700    1_
$a Toman, Daniel $u Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Surgery, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Urban, Ondřej $u Department of Internal Medicine II - Gastroenterology and Geriatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic
700    1_
$a Bužga, Marek $u Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic. marek.buzga@osu.cz $u Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. marek.buzga@osu.cz $1 https://orcid.org/000000029554737X
773    0_
$w MED00180469 $t Obesity surgery $x 1708-0428 $g Roč. 32, č. 11 (2022), s. 3666-3674
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36121606 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151400 $b ABA008
999    __
$a ok $b bmc $g 1891522 $s 1184168
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 32 $c 11 $d 3666-3674 $e 20220919 $i 1708-0428 $m Obesity surgery $n Obes Surg $x MED00180469
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace